Heart failure and first dose hypotension after angiotensin converting enzyme inhibitors

Area of Science:

• Cardiology
• Pharmacology

Background:

• First-dose hypotension is a concern with Angiotensin-Converting Enzyme (ACE) inhibitors.
• Clinicians express concern regarding the initial blood pressure drop after ACE inhibitor administration.

Purpose of the Study:

• To explore strategies for reducing the incidence and severity of first-dose hypotension with ACE inhibitors.
• To evaluate the role of specific ACE inhibitors in managing this side effect.

Main Methods:

• Review of clinical trials.
• Analysis of authors' clinical experience.
• Comparison of different ACE inhibitors regarding hypotensive effects.

Main Results:

• The incidence and severity of first-dose hypotension can be reduced.
• Specific ACE inhibitors, such as fosinopril and perindopril, demonstrate a lower propensity to cause hypotension compared to others.
• Appropriate clinical measures and drug selection are key to mitigating this risk.

Conclusions:

• ACE inhibitors can be safely used as a cornerstone treatment for chronic heart failure.
• Careful patient management and judicious selection of ACE inhibitors are crucial for minimizing first-dose hypotension.